Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology,
primarily affecting the joints, then extra-articular manifestations can occur. Due to its …

Rheumatoid arthritis (RA) is a heterogeneous disease with a complex and yet not fully
understood pathophysiology, where numerous different cell-types contribute to a destructive …

Abstract Treatment strategies for rheumatoid arthritis (RA) will continue to evolve as new
drugs are developed, as new data become available, and as our potential to achieve greater …

Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and
progressive autoimmune disease affecting many people worldwide. While patients show …

Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

Rheumatoid arthritis (RA) is characterised by severe joint and bone damage due to
heightened autoimmune response at the articular sites. Worldwide annual incidence and …

Rheumatoid arthritis (RA) is an autoimmune disease that involves multiple joints bilaterally.
It is characterized by an inflammation of the tendon (tenosynovitis) resulting in both cartilage …

Rheumatoid arthritis (RA) is an autoimmune disorder characterized by inflammation and
bone erosion. The exact mechanism of RA is still unknown, but various immune cytokines …

Few, if any, areas of medical therapeutics have witnessed such dramatic changes as those
that have occurred in the therapy of rheumatoid arthritis (RA) during the past two decades …

Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …